BEIJING ENT Reports Interim NP of RMB3.404B, an 8.1% Increase; Interim DPS at $0.85
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 28 2025
0mins
Source: aastocks
Company Overview: BEIJING ENT (00392.HK) reported its interim results for the period ending June 2025, showing a turnover increase of 5.2% year-over-year to RMB44.529 billion.
Profit Performance: The net profit for the company reached RMB3.404 billion, marking an 8.1% increase compared to the previous year, with earnings per share (EPS) at RMB2.71.
Dividend Declaration: An interim dividend per share (DPS) of $0.85 was declared, consistent with the same period last year.
Market Activity: The stock experienced short selling activity amounting to $3.00 million, with a short selling ratio of 7.162%.
Analyst Views on 00392
Wall Street analysts forecast 00392 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00392 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 32.060
Low
Averages
High
Current: 32.060
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
